Search - tctmd.com

Displaying 241 - 260 of 359

Sort: Relevancy | Date

Presentation TCT 2015

Paradoxical Embolic Myocardial Infarction: Analysis of More Than 6500 Patients With AMI

Presenter: David Hildick-Smith, Jonathan M. Tobis, Franz X. Kleber

October 14, 2015

Presentation TCT 2015

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

Presenter: David Hildick-Smith, Jonathan M. Tobis, Robert J. Sommer

October 14, 2015

Presentation TCT 2015

PRIMA Trial: Lessons Learned

Presenter: David Hildick-Smith, Jonathan M. Tobis

October 14, 2015

Presentation TCT 2015

PREMIUM Trial: Lessons Learned

Presenter: David Hildick-Smith, Jonathan M. Tobis

October 14, 2015

Presentation TCT 2015

Update on the ROPE Study: Emerging Insights

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

Presentation TCT 2015

Risk of Paradoxical Embolism With Pacemaker Leads

Presenter: John D. Carroll, Mark Reisman, Samir R. Kapadia

October 14, 2015

Presentation TCT 2015

Clinical Practice in 2015: When Closure Is and Is Not Justified

Presenter: John D. Carroll, Mark Reisman

October 14, 2015

Presentation TCT 2015

Meta-analysis of PFO Stroke Trials

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

News Conference News TCT 2015

PFO Closure Still Attracts Controversy

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

TCT 30: PREMIUM Trial Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

Presenter: John P. Cheatham, Carlos Pedra, Jonathan M. Tobis

October 13, 2015

Presentation TCT 2015

Congenital Heart Disease: PFO, ASD, VSD, and PDA

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 12, 2015

News Conference News TCT 2015

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

October 11, 2015

$PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura$

Presentation TCT 2014

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, David Hildick-Smith

September 16, 2014

Presentation TCT 2014

The Genetic Basis Of Patent Foramen Ovale

Presenter: Nabil Noureddin

September 16, 2014

News Conference News TCT 2014

PRIMA: PFO Closure Fails to Reduce Number of Migraine Days at 1 Year

Yael L. Maxwell

September 16, 2014

Presentation TCT 2014

An Illustrative ASD Case

Presenter: Ziyad M. Hijazi, John F. Rhodes, Roberto J Cubeddu

September 15, 2014

Presentation TCT 2014

Atrial Septal Defects: Evaluation and Management of the Adult with Pulmonary Hypertension

Presenter: Ziyad M. Hijazi, John F. Rhodes

September 15, 2014

Presentation TCT 2014

Intervention in the Fontan Patient

Presenter: Eric Horlick, Robert J. Sommer, Elchanan Bruckheimer, Frank F. Ing

September 14, 2014

Presentation TCT 2014

Invasive Evaluation of the Failing Fontan Patient

Presenter: Eric Horlick, Robert J. Sommer, Elchanan Bruckheimer, Matthew A Crystal

September 14, 2014

Presentation TCT 2014

The Fontan Circulation 101

Presenter: Eric Horlick, Robert J. Sommer, Elchanan Bruckheimer

September 14, 2014

Advertisement

Paradoxical Embolic Myocardial Infarction: Analysis of More Than 6500 Patients With AMI

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

PRIMA Trial: Lessons Learned

PREMIUM Trial: Lessons Learned

Update on the ROPE Study: Emerging Insights

Risk of Paradoxical Embolism With Pacemaker Leads

Clinical Practice in 2015: When Closure Is and Is Not Justified

Meta-analysis of PFO Stroke Trials

PFO Closure Still Attracts Controversy

TCT 30: PREMIUM Trial Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

Congenital Heart Disease: PFO, ASD, VSD, and PDA

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

The Genetic Basis Of Patent Foramen Ovale

PRIMA: PFO Closure Fails to Reduce Number of Migraine Days at 1 Year

An Illustrative ASD Case

Atrial Septal Defects: Evaluation and Management of the Adult with Pulmonary Hypertension

Intervention in the Fontan Patient

Invasive Evaluation of the Failing Fontan Patient

The Fontan Circulation 101

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content